Growth and survival of lung cancer cells: regulation by kallikrein-related peptidase 6 via activation of proteinase-activated receptor 2 and the epidermal growth factor receptor
- 19 March 2014
- journal article
- Published by Walter de Gruyter GmbH in Biological Chemistry
- Vol. 395 (9) , 1015-1025
Abstract
The dysregulated expression of kallikrein-related peptidase 6 (KLK6) is involved in non-small cancer (NSCLC) cell growth. However, the mechanism that sustains KLK6 signaling remains unknown. We used an isogenic non-small cell lung cancer (NSCLC) cell model system to demonstrate that KLK6 promotes the proliferation of lung tumoral cells and restrains their apoptosis in vitro via ligand-dependent EGFR transactivation. KLK6 activated the ERK and Akt pathways and triggered the nuclear translocation of β-catenin. The stimulating effects of KLK6 required its proteolytic activity and were dependent on the protease-activated receptor 2 (PAR2). These observations support the concept of a role for KLK6 in the oncogenesis of NSCLC.Keywords
This publication has 14 references indexed in Scilit:
- The many faces and functions of β‐cateninThe EMBO Journal, 2012
- Pathophysiological functions of cathepsin D: Targeting its catalytic activity versus its protein binding activity?Biochimie, 2010
- Epidermal growth factor receptor regulates β-catenin location, stability, and transcriptional activity in oral cancerMolecular Cancer, 2010
- EGFR ligands and their signaling scissors, ADAMs, as new molecular targets for anticancer treatmentsJournal of Dermatological Science, 2009
- High kallikrein‐related peptidase 6 in non‐small cell lung cancer cells: an indicator of tumour proliferation and poor prognosisJournal of Cellular and Molecular Medicine, 2009
- Association of KLK5 overexpression with invasiveness of urinary bladder carcinoma cellsCancer Science, 2007
- The Autolytic Regulation of Human Kallikrein-Related Peptidase 6Biochemistry, 2007
- Clinicopathologic and Biological Significance of Kallikrein 6 Overexpression in Human Gastric CancerClinical Cancer Research, 2005
- Human Kallikrein 6 Degrades Extracellular Matrix Proteins and May Enhance the Metastatic Potential of Tumour CellsTumor Biology, 2004
- In silico Analysis of the Human Kallikrein Gene 6Tumor Biology, 2004